Interferon Alpha-2a for the Treatment of Cystoid Macular Edema Secondary to Acute Retinal Necrosis

References

• Holland GN. Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive committee of the American Uveitis Society. Am J Ophthalmol. 1994;117:663–667. doi:10.1016/s0002-9394(14)70075-3.
   PubMed Web of Science ®Google Scholar
• Wong RW, Jumper JM, McDonald HR, et al. Emerging concepts in the management of acute retinal necrosis. Br J Ophthalmol. 2013;97:545–552. doi:10.1136/bjophthalmol-2012-301983.
   PubMed Web of Science ®Google Scholar
• Lau CH, Missotten T, Salzmann J, Lightman SL. Acute retinal necrosis features, management, and outcomes. Ophthalmology. 2007;114:756–762. doi:10.1016/j.ophtha.2006.08.037.
   PubMed Web of Science ®Google Scholar
• Fonollosa A, Llorenç V, Artaraz J, et al. Safety and efficacy of intravitreal dexamethasone implants in the management of macular edema secondary to infectious uveitis. Retina. 2016;36:1778–1785. doi:10.1097/IAE.0000000000001001.
   PubMed Web of Science ®Google Scholar
• Majumder PD, Biswas J, Ambreen A, Amin R, Pannu ZR, Bedda AM. Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis. J Ophthalmic Inflamm Infect. 2016;6:49. doi:10.1186/s12348-016-0116-x.
   PubMed Web of Science ®Google Scholar
• Ortega-Evangelio L, Navarrete-Sanchis J, Williams BK, Tomás-Torrent JM. Aflibercept in the management of acute retinal necrosis syndrome-related macular edema. Eur J Ophthalmol. 2018;28:259–261. doi:10.5301/ejo.5001039.
   PubMed Web of Science ®Google Scholar
• Amselem L, Diaz-Llopis M, Cervera E, Salom D, Huste F, Montero J. Pegaptanib sodium for acute retinal necrosis-induced macular oedema. Acta Ophthalmol. 2010;88:e42–3. doi:10.1111/j.1755-3768.2008.01351.x.
   PubMed Web of Science ®Google Scholar
• Sánchez Ramón A, Piñón Mosquera R, Mendieta Rasos N. Response to anti-VEGF therapy in macular oedema secondary to acute retinal necrosis. Arch Soc Esp Oftalmol. 2019;94:41–44. English, Spanish. doi:10.1016/j.oftal.2018.07.007.
   PubMedGoogle Scholar
• Kötter I, Zierhut M, Eckstein AK, et al. Human recombinant interferon alfa-2a for the treatment of Behçet’s disease with sight threatening posterior or panuveitis. Br J Ophthalmol. 2003;87:423–431. doi:10.1136/bjo.87.4.423.
   PubMed Web of Science ®Google Scholar
• Deuter CM, Kötter I, Günaydin I, Stübiger N, Doycheva DG, Zierhut M. Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis. Br J Ophthalmol. 2009;93:906–913. doi:10.1136/bjo.2008.153874.
   PubMed Web of Science ®Google Scholar
• Butler NJ, Suhler EB, Rosenbaum JT. Interferon alpha 2b in the treatment of uveitic cystoid macular edema. Ocul Immunol Inflamm. 2012;20:86–90. doi:10.3109/09273948.2011.645989.
   PubMed Web of Science ®Google Scholar
• Stiefel HC, Kopplin LJ, Albini T, Chang M, Vegunta S, Suhler EB. Treatment of refractory cystoid macular edema with pegylated interferon alfa-2a: a retrospective chart review. Ocul Immunol Inflamm. 2019;19:1–6. doi:10.1080/09273948.2019.1687729.
   Google Scholar
• Couret C, Servant M, Lebranchu P, Hamidou M, Weber M. Efficacy and safety of interferon alpha 2a and pegylated interferon alpha 2a in inflammatory macular edema. Ocul Immunol Inflamm. 2020;28:329–336. doi:10.1080/09273948.2019.1604001.
   PubMed Web of Science ®Google Scholar
• Deuter CM, Koetter I, Guenaydin I, Stuebiger N, Zierhut M. Interferon alfa-2a: a new treatment option for long lasting refractory cystoid macular edema in uveitis? A pilot study. Retina. 2006;26:786–791. doi:10.1097/01.iae.0000244265.75771.71.
   PubMed Web of Science ®Google Scholar
• De Simone L, Sangiovanni A, Aldigeri R, et al. Interferon alpha-2a treatment for post-uveitic refractory macular edema. Ocul Immunol Inflamm. 2020;28:322–328. doi:10.1080/09273948.2019.1589526.
   PubMed Web of Science ®Google Scholar
• Fardeau C, Simon A, Rodde B, et al. Interferon-alpha2a and systemic corticosteroid in monotherapy in chronic uveitis: results of the randomized controlled BIRDFERON study. Am J Ophthalmol. 2017;177:182–194. doi:10.1016/j.ajo.2017.03.001.
   PubMed Web of Science ®Google Scholar
• Qian Z, Fardeau C, Cardoso JN, Jellab B, Fan X, LeHoang P. Effect of interferon α2a in cystoid macular edema due to intraocular infection. Eur J Ophthalmol. 2015;25:431–436. doi:10.5301/ejo.5000591.
   PubMed Web of Science ®Google Scholar
• Izambart C, Zur C, Fiandrino P, Tieulie N, Cassoux N, Gastaud P. Prise en charge du syndrome de nécrose rétinienne aiguë compliqué d’oedème maculaire cystoïde [Management of acute retinal necrosis syndrome with cystoid macular edema: a case report]. J Fr Ophtalmol. 2009;32:60.e1–6. French. doi:10.1016/j.jfo.2008.10.001.
   PubMedGoogle Scholar
• Oray M, Onal S, Uludag G, Akbay AK, Tugal-Tutkun I. Interferon alpha for the treatment of cystoid macular edema associated with presumed ocular tuberculosis. J Ocul Pharmacol Ther. 2017;33:304–312. doi:10.1089/jop.2016.0097.
   PubMed Web of Science ®Google Scholar
• Invernizzi A, Iannaccone F, Marchi S, et al. Interferon alpha-2a for the treatment of post-infectious uveitis secondary to presumed intraocular tuberculosis. Ocul Immunol Inflamm. 2019;27:643–650. doi:10.1080/09273948.2018.1431292.
   PubMed Web of Science ®Google Scholar
• Butler NJ, Moradi A, Salek SS, et al. Acute retinal necrosis: presenting characteristics and clinical outcomes in a cohort of polymerase chain reaction-positive patients. Am J Ophthalmol. 2017;179:179–189. doi:10.1016/j.ajo.2017.05.006.
   PubMed Web of Science ®Google Scholar
• Baltinas J, Lightman S, Tomkins-Netzer O. Comparing treatment of acute retinal necrosis with either oral valacyclovir or ıntravenous acyclovir. Am J Ophthalmol. 2018;188:173–180. doi:10.1016/j.ajo.2018.02.001.
   PubMed Web of Science ®Google Scholar
• Dave VP, Pappuru RR, Pathengay A, Tyagi M, Narayanan R, Jalali S. Vitrectomy with silicone oil tamponade in rhegmatogenous retinal detachment following acute retinal necrosis: clinical outcomes and prognostic factors. Semin Ophthalmol. 2019;34:47–51. doi:10.1080/08820538.2018.1551907.
   PubMed Web of Science ®Google Scholar
• Bae SH, Hwang JS, Yu HG. Comparative analysis of macular microstructure by spectral-domain optical coherence tomography before and after silicone oil removal. Retina. 2012;32:1874–1883. doi:10.1097/IAE.0b013e318246907c.
   PubMed Web of Science ®Google Scholar
• Yang JY, Kim HK, Kim SH, Kim SS. Incidence and risk factors of cystoid macular edema after vitrectomy with silicone oil tamponade for retinal detachment. Korean J Ophthalmol. 2018;32:204–210. doi:10.3341/kjo.2017.0050.
   PubMedGoogle Scholar
• Azzolini C, Donati S, Caprani SM, et al. Macular edema and silicone oil tamponade. J Clin Exp Ophthalmol. 2014;5:6. doi:10.4172/2155-9570.1000366.
   Google Scholar
• Kaneko H, Takayama K, Asami T, et al. Cytokine profiling in the sub-silicone oil fluid after vitrectomy surgeries for refractory retinal diseases. Sci Rep. 2017;7:2640. doi:10.1038/s41598-017-03124-x.
   PubMed Web of Science ®Google Scholar
• Shimizu H, Kaneko H, Suzumura A, et al. Biological characteristics of subsilicone oil fluid and differences with other ocular humors. Transl Vis Sci Technol. 2019 Feb 28;8(1):28. doi:10.1167/tvst.8.1.28.
   PubMed Web of Science ®Google Scholar
• Wickham LJ, Asaria RH, Alexander R, Luthert P, Charteris DG. Immunopathology of intraocular silicone oil: retina and epiretinal membranes. Br J Ophthalmol. 2007 Feb;91(2):258–262. doi:10.1136/bjo.2006.103549.
   PubMed Web of Science ®Google Scholar
• Takakura A, Tessler HH, Goldstein DA, et al. Viral retinitis following intraocular or periocular corticosteroid administration: a case series and comprehensive review of the literature. Ocul Immunol Inflamm. 2014;22:175–182. doi:10.3109/09273948.2013.866256.
   PubMed Web of Science ®Google Scholar
• Vertes D, Snyers B, De Potter P. Cytomegalovirus retinitis after low-dose intravitreous triamcinolone acetonide in an immunocompetent patient: a warning for the widespread use of intravitreous corticosteroids. Int Ophthalmol. 2010;30:595–597. doi:10.1007/s10792-010-9404-x.
   PubMedGoogle Scholar
• Saidel MA, Berreen J, Margolis TP. Cytomegalovirus retinitis after intravitreous triamcinolone in an immunocompetent patient. Am J Ophthalmol. 2005;140:1141–1143. doi:10.1016/j.ajo.2005.06.058.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Araz B, Cagatay A. CMV retinitis after intravitreal triamcinolone acetonide injection in a patient with Behçet’s uveitis. Int Ophthalmol. 2010;30:591–593. doi:10.1007/s10792-009-9332-9.
   PubMedGoogle Scholar
• Vannozzi L, Bacherini D, Sodi A, et al. Cytomegalovirus retinitis following intravitreal dexamethasone implant in a patient with central retinal vein occlusion. Acta Ophthalmol. 2016;94:e158–60. doi:10.1111/aos.12783.
   PubMed Web of Science ®Google Scholar
• Oray M, Ozdal PC, Cebeci Z, Kir N, Tugal-Tutkun I. Fulminant ocular toxoplasmosis: the hazards of corticosteroid monotherapy. Ocul Immunol Inflamm. 2016;24:637–646. doi:10.3109/09273948.2015.1057599.
   PubMed Web of Science ®Google Scholar
• Rush R, Sheth S. Fulminant toxoplasmic retinochoroiditis following intravitreal triamcinolone administration. Indian J Ophthalmol. 2012;60:141–143. doi:10.4103/0301-4738.94059.
   PubMed Web of Science ®Google Scholar
• Olson DJ, Parhiz AT, Wirthlin RS. Reactivation of latent toxoplasmosis following dexamethasone implant ınjection. Ophthalmic Surg Lasers Imaging Retina. 2016;47:1050–1052. doi:10.3928/23258160-20161031-10.
   PubMed Web of Science ®Google Scholar
• Ahmed A, Sudharshan S, Gopal S, Majumder PD, Biswas J. Toxoplasma retinitis following intravitreal injection of triamcinolone acetonide: a case report and review of literature. Indian J Ophthalmol. 2018;66:1205–1208. doi:10.4103/ijo.IJO_142_18.
   PubMed Web of Science ®Google Scholar
• Song JH, Hong YT, Kwon OW. Acute syphilitic posterior placoid chorioretinitis following intravitreal triamcinolone acetonide injection. Graefes Arch Clin Exp Ophthalmol. 2008;246:1775–1778. doi:10.1007/s00417-008-0928-y.
   PubMed Web of Science ®Google Scholar
• Erol N, Topbas S. Acute syphilitic posterior placoid chorioretinitis after an intravitreal triamcinolone acetonide injection. Acta Ophthalmol Scand. 2006;84:435. doi:10.1111/j.1600-0420.2005.00641.x.
   PubMedGoogle Scholar
• Boyer DS, Yoon YH, Jr BR, Ozurdex MEAD Study Group, et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 2014;121:1904–1914. doi:10.1016/j.ophtha.2014.04.024.
   PubMed Web of Science ®Google Scholar
• Toh T, Borthwick JH. Acute retinal necrosis post intravitreal injection of triamcinolone acetonide. Clin Exp Ophthalmol. 2006;34:380–382. doi:10.1111/j.1442-9071.2006.01229.x.
   PubMed Web of Science ®Google Scholar
• Kucukevcilioglu M, Eren M, Yolcu U, Sobaci G. Acute retinal necrosis following intravitreal dexamethasone (Ozurdex®) implant. Arq Bras Oftalmol. 2015;78:118–119. doi:10.5935/0004-2749.20150030.
   PubMed Web of Science ®Google Scholar
• Zhang ZY, Liu XY, Jiang T. Acute retinal necrosis following dexamethasone intravitreal implant (Ozurdex®) administration in an immunocompetent adult with a history of HSV encephalitis: a case report. BMC Ophthalmol. 2020 22;20:247. doi:10.1186/s12886-020-01514-w.
   PubMed Web of Science ®Google Scholar
• Gillies MC, Su T. Interferon alpha-2b enhances barrier function of bovine retinal microvascular endothelium in vitro. Microvasc Res. 1995;49:277–288. doi:10.1006/mvre.1995.1024.
   PubMed Web of Science ®Google Scholar
• Dimopoulos S, Deuter CME, Blumenstock G, et al. Interferon alpha for refractory pseudophakic cystoid macular edema (Irvine-Gass syndrome). Ocul Immunol Inflamm. 2020;28:315–321. doi:10.1080/09273948.2019.1585883.
   PubMed Web of Science ®Google Scholar